Position in APGE
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,424,591
+$676,657 QoQ
Shares Held
10,733
+20.8% QoQ
Ownership
0.014%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#167
of 285 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in APGE Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ProShare Advisors LLC holds $336,334,656 across 174 Biotechnology names. APGE ranks #10 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
287,847 | $142,982,240 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
119,240 | $74,350,909 | |
| 3 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
128,514 | $38,686,569 | |
| 4 | INCY |
Incyte Corp
|
48,152 | $5,458,510 | |
| 5 | MRNA |
Moderna, Inc.
|
70,621 | $4,945,588 | |
| 6 | CYTK |
Cytokinetics Inc
|
27,121 | $2,310,437 | |
| 7 | TECH |
BIO-TECHNE Corp
|
30,597 | $2,161,678 | |
| 8 | KRYS |
Krystal Biotech, Inc.
|
4,760 | $1,769,149 |
All Filings in APGE
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,424,591 | 10,733 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $747,934 | 8,886 | Shares | Sole | 2026-04-27 | |
| 2025-12-31 | $714,342 | 9,464 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $287,764 | 7,243 | Shares | Sole | 2025-11-06 | |
| 2025-06-30 | $358,948 | 8,265 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $382,379 | 10,235 | Shares | Sole | 2025-05-08 | |
| 2024-12-31 | $580,066 | 12,805 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $576,826 | 9,820 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $327,234 | 8,316 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $667,025 | 10,038 | Shares | Sole | 2024-05-08 | |
| No filing history on record for this holder in this stock. | ||||||